Potentiation of Thromboxane A2-induced Platelet Secretion by Gi Signaling through the Phosphoinositide-3 Kinase Pathway
暂无分享,去创建一个
S. Kunapuli | C. Dangelmaier | J. Smith | Jianguo Jin | Bryan R. E. Smith | J. Jin | Carol Dangelmaier
[1] A. Elzagallaai,et al. Platelet secretion induced by phorbol esters stimulation is mediated through phosphorylation of MARCKS: a MARCKS-derived peptide blocks MARCKS phosphorylation and serotonin release without affecting pleckstrin phosphorylation. , 2000, Blood.
[2] B. Payrastre,et al. A key role of adenosine diphosphate in the irreversible platelet aggregation induced by the PAR1-activating peptide through the late activation of phosphoinositide 3-kinase. , 1999, Blood.
[3] S. Kunapuli,et al. Molecular Mechanism of Thromboxane A2-induced Platelet Aggregation , 1999, The Journal of Biological Chemistry.
[4] S. Kunapuli,et al. Role of Intracellular Signaling Events in ADP-induced Platelet Aggregation , 1999, Thrombosis and Haemostasis.
[5] S. Kunapuli,et al. Platelet Shape Change Is Mediated by both Calcium-dependent and -independent Signaling Pathways , 1999, The Journal of Biological Chemistry.
[6] J. Fox,et al. Calpain Mediates Integrin-induced Signaling at a Point Upstream of Rho Family Members* , 1999, The Journal of Biological Chemistry.
[7] S. Coughlin,et al. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin. , 1999, The Journal of clinical investigation.
[8] M. Simon,et al. Activation of G12/G13 Results in Shape Change and Rho/Rho-Kinase–mediated Myosin Light Chain Phosphorylation in Mouse Platelets , 1999, The Journal of cell biology.
[9] G. FitzGerald,et al. Phosphorylation of the Thromboxane Receptor α, the Predominant Isoform Expressed in Human Platelets* , 1999, The Journal of Biological Chemistry.
[10] S. Kunapuli,et al. Multiple P2 receptor subtypes on platelets: a new interpretation of their function. , 1998, Trends in pharmacological sciences.
[11] S. Volinia,et al. A Type II Phosphoinositide 3-Kinase Is Stimulated via Activated Integrin in Platelets , 1998, The Journal of Biological Chemistry.
[12] S. Kunapuli,et al. Molecular Basis for ADP-induced Platelet Activation , 1998, The Journal of Biological Chemistry.
[13] R. Haslam,et al. Protein kinase C-dependent and Ca2+-dependent mechanisms of secretion from streptolysin O-permeabilized platelets: effects of leakage of cytosolic proteins. , 1997, The Biochemical journal.
[14] R. Carroll,et al. Blocking platelet aggregation inhibits thromboxane A2 formation by low dose agonists but does not inhibit phosphorylation and activation of cytosolic phospholipase A2. , 1997, Thrombosis research.
[15] Stefan Offermanns,et al. Defective platelet activation in Gαq-deficient mice , 1997, Nature.
[16] L. Brass,et al. Signaling through G Proteins in Platelets: to the Integrins and Beyond , 1997, Thrombosis and Haemostasis.
[17] T. K. Harden,et al. Identification of competitive antagonists of the P2Y1 receptor. , 1996, Molecular pharmacology.
[18] S. Rhee,et al. Decreased expression of phospholipase C-beta 2 isozyme in human platelets with impaired function. , 1996, Blood.
[19] S. Narumiya,et al. Two thromboxane A2 receptor isoforms in human platelets. Opposite coupling to adenylyl cyclase with different sensitivity to Arg60 to Leu mutation. , 1996, The Journal of clinical investigation.
[20] M. J. Robertson,et al. A novel series of P2T purinoceptor antagonists: definition of the role of ADP in arterial thrombosis. , 1995, Trends in pharmacological sciences.
[21] P. Gazzaniga,et al. Protein kinase C activation is not a key step in ADP‐mediated exposure of fibrinogen receptors on human platelets , 1995, FEBS letters.
[22] A. Toker,et al. Phosphoinositide 3-kinase inhibition spares actin assembly in activating platelets but reverses platelet aggregation , 1995, The Journal of Biological Chemistry.
[23] J. Parsons,et al. Tyrosine phosphorylation of pp125FAK in platelets requires coordinated signaling through integrin and agonist receptors. , 1994, The Journal of biological chemistry.
[24] J. White,et al. Role of actin in platelet function. , 1993, European journal of cell biology.
[25] J. Pouysségur,et al. A peptide ligand of the human thrombin receptor antagonizes alpha-thrombin and partially activates platelets. , 1993, The Journal of biological chemistry.
[26] J. Zablocki,et al. Potent in vitro and in vivo inhibitors of platelet aggregation based upon the Arg-Gly-Asp-Phe sequence of fibrinogen. A proposal on the nature of the binding interaction between the Arg-guanidine of RGDX mimetics and the platelet GP IIb-IIIa receptor. , 1993, Journal of medicinal chemistry.
[27] P. Mannucci,et al. Identification of a new congenital defect of platelet function characterized by severe impairment of platelet responses to adenosine diphosphate. , 1992, Blood.
[28] V. Kakkar,et al. Mastoparan promotes exocytosis and increases intracellular cyclic AMP in human platelets. Evidence for the existence of a Ge-like mechanism of secretion. , 1992, The Biochemical journal.
[29] S. Hourani,et al. Pharmacological receptors on blood platelets. , 1991, Pharmacological reviews.
[30] A. Bielawska,et al. Diacylglycerol overcomes aspirin inhibition of platelets: evidence for a necessary role for diacylglycerol accumulation in platelet activation. , 1991, Molecular pharmacology.
[31] J. Maraganore,et al. Binding of the snake venom-derived proteins applaggin and echistatin to the arginine-glycine-aspartic acid recognition site(s) on platelet glycoprotein IIb.IIIa complex inhibits receptor function. , 1990, The Journal of biological chemistry.
[32] J. Disa,et al. Impaired cytoplasmic ionized calcium mobilization in inherited platelet secretion defects. , 1989, Blood.
[33] S. Niewiarowski,et al. Trigramin. A low molecular weight peptide inhibiting fibrinogen interaction with platelet receptors expressed on glycoprotein IIb-IIIa complex. , 1987, The Journal of biological chemistry.
[34] L. Brass,et al. Activation of phospholipases A and C in human platelets exposed to epinephrine: role of glycoproteins IIb/IIIa and dual role of epinephrine. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[35] J. Sweatt,et al. Evidence that Na+/H+ exchange regulates receptor-mediated phospholipase A2 activation in human platelets. , 1986, The Journal of biological chemistry.
[36] J. Sweatt,et al. Inhibitors of Na+/H+ exchange block stimulus-provoked arachidonic acid release in human platelets. Selective effects on platelet activation by epinephrine, ADP, and lower concentrations of thrombin. , 1985, The Journal of biological chemistry.
[37] H. Holmsen,et al. Platelet secretion defect associated with impaired liberation of arachidonic acid and normal myosin light chain phosphorylation. , 1984, Blood.
[38] D. Macfarlane,et al. 2-Methylthioadenosine[beta-32P]diphosphate. An agonist and radioligand for the receptor that inhibits the accumulation of cyclic AMP in intact blood platelets. , 1983, The Journal of clinical investigation.
[39] J. White,et al. Effects of a microtubule stabilizing agent on the response of platelets to vincristine. , 1982, Blood.
[40] Jonathan L. Costa,et al. Platelet 5-HT uptake and release stopped rapidly by formaldehyde , 1975, Nature.
[41] M. Aepfelbacher,et al. Dichotomous regulation of myosin phosphorylation and shape change by Rho-kinase and calcium in intact human platelets. , 1999, Blood.
[42] N. Dhanasekaran,et al. Platelet signal transduction defect with Galpha subunit dysfunction and diminished Galphaq in a patient with abnormal platelet responses. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[43] J. Zhang,et al. Phosphoinositide 3-kinase gamma and p85/phosphoinositide 3-kinase in platelets. Relative activation by thrombin receptor or beta-phorbol myristate acetate and roles in promoting the ligand-binding function of alphaIIbbeta3 integrin. , 1996, The Journal of biological chemistry.
[44] P. Hawkins,et al. A novel phosphoinositide 3 kinase activity in myeloid-derived cells is activated by G protein beta gamma subunits. , 1994, Cell.
[45] S. Watson,et al. Synergy between Ca2+ and protein kinase C is the major factor in determining the level of secretion from human platelets. , 1993, The Biochemical journal.
[46] J. White,et al. The platelet open canalicular system: a final common pathway. , 1991, Blood cells.